For a pharmaceutical company, the most suitable base for allocating research and development costs to the finished products would be the ________. A. direct labor hours B. number of set ups C. cost of raw materials purchased D. number of new patents filed
For a pharmaceutical company, the most suitable base for allocating research and development costs to the finished products would be the number of new patents filed